Filings

Finds words inside filing documents. Searching Pelthos Therapeutics Inc.'s filings · 58 documents indexed.

8 documents · 44 matches

PTHS Pelthos Therapeutics Inc. 10-Q 2026-11-12

Item 1A. Risk Factors
material weakness resulted in a material misstatement of our convertible debt, change in fair value of convertible debt, other comprehensive
11 matches in this document
PTHS Pelthos Therapeutics Inc. 10-Q 2026-08-13

Item 1A. Risk Factors
material weakness resulted in a material misstatement of our convertible debt, change in fair value of convertible debt, other comprehensive
11 matches in this document
PTHS Pelthos Therapeutics Inc. 10-Q/A 2026-08-13

Item 1A. Risk Factors
material weakness resulted in a material misstatement of our convertible debt, change in fair value of convertible debt, other comprehensive
12 matches in this document
PTHS Pelthos Therapeutics Inc. 10-K 2026-03-19

Item 1A. Risk Factors
material weaknesses in our internal control over financial reporting. A material weakness is a deficiency, or a combination of deficiencies
5 matches in this document
PTHS Pelthos Therapeutics Inc. 8-K 2026-08-13

Item 4.02. (a). Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review.
material weakness in its internal control over financial reporting that existed as of March 31, 2026, and which continues to exist
2 matches in this document
PTHS Pelthos Therapeutics Inc. 10-Q 2025-11-13

Item 4. Controls and Procedures.
Management identified the following material weaknesses:
1 match in this document
PTHS Pelthos Therapeutics Inc. 10-Q 2025-08-13

Item 4. Controls and Procedures.
Management identified the following material weaknesses:
1 match in this document
PTHS Pelthos Therapeutics Inc. 10-Q 2025-05-13

Item 4. Controls and Procedures.
Management identified the following material weaknesses:
1 match in this document

Page 1 of 1 · 8 documents